These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30877950)

  • 1. Cytokine profile of macrophage activation syndrome associated with Kawasaki disease.
    Jinkawa A; Shimizu M; Nishida K; Kaneko S; Usami M; Sakumura N; Irabu H; Takakuwa M; Inoue N; Mizuta M; Ikawa Y; Fujita S; Yachie A
    Cytokine; 2019 Jul; 119():52-56. PubMed ID: 30877950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children.
    Mizuta M; Shimizu M; Irabu H; Usami M; Inoue N; Nakagishi Y; Wada T; Yachie A
    Rheumatology (Oxford); 2021 Jan; 60(1):231-238. PubMed ID: 32681176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy.
    Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    Pediatr Res; 2020 Dec; 88(6):934-939. PubMed ID: 32184444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Takakura M; Shimizu M; Irabu H; Sakumura N; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    Clin Immunol; 2019 Nov; 208():108252. PubMed ID: 31449879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of serum soluble TNF receptor II level and soluble TNF receptor II/I ratio as indicators of coronary artery lesion development in Kawasaki disease.
    Shimizu M; Mizuta M; Usami M; Inoue N; Sakakibara Y; Yamada K; Konishi M; Ohta K; Yachie A
    Cytokine; 2018 Aug; 108():168-172. PubMed ID: 29625336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of serum cytokine profiles for differentiating between Kawasaki disease and its mimickers.
    Kaneko S; Shimizu M; Shimbo A; Irabu H; Yokoyama K; Furuno K; Tanaka T; Ueno K; Fujita S; Iwata N; Fujimura J; Akamine K; Mizuta M; Nakagishi Y; Minato T; Watanabe K; Kobayashi A; Endo T; Tabata K; Mori M; Morio T
    Cytokine; 2023 Sep; 169():156280. PubMed ID: 37356260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of Serum Soluble TNF Receptor I/II Ratio for the Differential Diagnosis of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome From Other Autoinflammatory Diseases.
    Yasumura J; Shimizu M; Toma T; Yashiro M; Yachie A; Okada S
    Front Immunol; 2020; 11():576152. PubMed ID: 33162992
    [No Abstract]   [Full Text] [Related]  

  • 8. Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis.
    Sakumura N; Shimizu M; Mizuta M; Inoue N; Nakagishi Y; Yachie A
    Cytokine; 2018 Oct; 110():459-465. PubMed ID: 29801971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
    Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive serum biomarker analysis in patients with macrophage activation syndrome associated with systemic lupus erythematosus.
    Usami M; Shimizu M; Mizuta M; Inoue N; Irabu H; Sakumura N; Nakagishi Y; Yachie A
    Clin Immunol; 2019 Nov; 208():108255. PubMed ID: 31476438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do cytokines correlate with refractory Kawasaki disease in children?
    Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z
    Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac function on 3-D speckle tracking imaging and cytokines in Kawasaki disease.
    Kato M; Ayusawa M; Watanabe H; Komori A; Abe Y; Nakamura T; Kamiyama H; Takahashi S
    Pediatr Int; 2018 Apr; 60(4):342-348. PubMed ID: 29350882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of proinflammatory cytokine inhibitors (sTNFR I, sTNFR II, IL-1 ra), anti-inflammatory cytokines (IL-10, IL-13) and activation of neutrophils after burn-induced inflammation.
    Sikora JP; Chlebna-Sokół D; Andrzejewska E; Chrul S; Polakowska E; Wysocka A; Sikora A
    Scand J Immunol; 2008 Aug; 68(2):145-52. PubMed ID: 18702744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes.
    Mangge H; Kenzian H; Gallistl S; Neuwirth G; Liebmann P; Kaulfersch W; Beaufort F; Muntean W; Schauenstein K
    Arthritis Rheum; 1995 Feb; 38(2):211-20. PubMed ID: 7848311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
    Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M
    Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Laboratory Profile of Macrophage Activation Syndrome in Kawasaki Disease: A Single Centre Cross-Sectional Study.
    Maheshwari A; Gulati S; Kakkar V; Kavya DR; Aggarwal M; Basu S; Mahto D
    Indian Pediatr; 2024 Aug; 61(8):723-729. PubMed ID: 38859648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients.
    Hachiya A; Kobayashi N; Matsuzaki S; Takeuchi Y; Akazawa Y; Shigemura T; Motoki N; Masumoto J; Agematsu K
    Clin Rheumatol; 2018 Jul; 37(7):1937-1943. PubMed ID: 29302828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage activation syndrome in Kawasaki disease: more common than we thought?
    Wang W; Gong F; Zhu W; Fu S; Zhang Q
    Semin Arthritis Rheum; 2015 Feb; 44(4):405-10. PubMed ID: 25200945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features of Kawasaki disease complicated by macrophage activation syndrome: an analysis of 27 cases].
    Wen YN; Chen J; Liu F; Ding Y; Yin W
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jun; 25(6):572-578. PubMed ID: 37382125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.
    Sikora JP; Kuzański W; Andrzejewska E
    Med Sci Monit; 2009 Jan; 15(1):CR26-31. PubMed ID: 19114968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.